Latest Articles
Antibody therapy points to a new treatment era for primary membranous nephropathy - Drug Discovery News
Antibody therapy points to a new treatment era for primary membranous nephropathy Drug Discovery News
Published: June 16, 2026, 9:19 p.m.
FDA’s drug repurposing initiative signals renewed focus - Drug Discovery News
FDA’s drug repurposing initiative signals renewed focus Drug Discovery News
Published: June 10, 2026, 6:26 p.m.
An AI model decodes tumor mutations to predict treatment response - Drug Discovery News
An AI model decodes tumor mutations to predict treatment response Drug Discovery News
Published: June 1, 2026, 7:29 p.m.
Why 2026 could be a turning point for patient-focused trials - Drug Discovery News
Why 2026 could be a turning point for patient-focused trials Drug Discovery News
Published: May 28, 2026, 12:56 p.m.
Designing microbiome therapies at scale starts with manufacturing - Drug Discovery News
Designing microbiome therapies at scale starts with manufacturing Drug Discovery News
Published: May 26, 2026, 6:52 p.m.
Is this the first disease-modifying treatment for endometriosis? - Drug Discovery News
Is this the first disease-modifying treatment for endometriosis? Drug Discovery News
Published: May 20, 2026, 8:03 p.m.
How the Iran war is quietly testing global drug supply chains - Drug Discovery News
How the Iran war is quietly testing global drug supply chains Drug Discovery News
Published: April 26, 2026, 7:07 a.m.
Weekly Rundown: Lilly expands in vivo CAR T push with $7B Kelonia deal - Drug Discovery News
Weekly Rundown: Lilly expands in vivo CAR T push with $7B Kelonia deal Drug Discovery News
Published: April 24, 2026, 9:20 p.m.
SEQSTER CEO Ardy Arianpour on AWS BioDiscovery, fragmented health records and AI drug discovery’s missing patient layer - R&D World
SEQSTER CEO Ardy Arianpour on AWS BioDiscovery, fragmented health records and AI drug discovery’s missing patient layer R&D World
Published: April 24, 2026, 8:29 p.m.
SEQSTER CEO Ardy Arianpour on AWS Bio Discovery, fragmented health records and AI drug discovery’s missing patient layer - R&D World
SEQSTER CEO Ardy Arianpour on AWS Bio Discovery, fragmented health records and AI drug discovery’s missing patient layer R&D World
Published: April 24, 2026, 8:29 p.m.
Link copied to clipboard!